Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Increases Dividend to $0.87 Per Share

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) declared an annual dividend on Friday, May 1st. Investors of record on Friday, May 22nd will be given a dividend of 0.8716 per share on Monday, June 8th. This represents a yield of 385.0%. The ex-dividend date of this dividend is Friday, May 22nd. This is a 10.7% increase from Fresenius Medical Care AG & Co. KGaA’s previous annual dividend of $0.79.

Fresenius Medical Care AG & Co. KGaA has raised its dividend payment by an average of 0.0%annually over the last three years. Fresenius Medical Care AG & Co. KGaA has a payout ratio of 25.8% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Fresenius Medical Care AG & Co. KGaA to earn $2.43 per share next year, which means the company should continue to be able to cover its $0.61 annual dividend with an expected future payout ratio of 25.1%.

Fresenius Medical Care AG & Co. KGaA Stock Performance

NYSE:FMS opened at $22.12 on Wednesday. The firm has a market capitalization of $12.36 billion, a PE ratio of 11.64, a price-to-earnings-growth ratio of 4.01 and a beta of 0.81. The business’s fifty day moving average price is $22.47 and its 200 day moving average price is $23.14. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.20 and a quick ratio of 0.86. Fresenius Medical Care AG & Co. KGaA has a 12 month low of $20.02 and a 12 month high of $30.46.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last posted its earnings results on Tuesday, March 31st. The company reported $1.05 EPS for the quarter. The firm had revenue of $5.34 billion for the quarter. Fresenius Medical Care AG & Co. KGaA had a return on equity of 8.90% and a net margin of 4.88%. On average, sell-side analysts anticipate that Fresenius Medical Care AG & Co. KGaA will post 2.24 earnings per share for the current fiscal year.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high?flux dialyzers and bloodlines.